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BACKGROUND 
Diarrhoea is a common symptom of
gastrointestinal illness, ranking among
the 20 most frequest reasons for patient
encounters in general practice 
in Australia. Children under 5 years of
age are especially vulnerable to bacterial
gastroenteritis such as infections with
Campylobacter jejuni. Everyday diet, in
particular the regular consumption of pro-
and pre-biotics, can help 
with the maintenance of a healthy
gastrointestinal system. 
OBJECTIVE
This article outlines the potential of
‘everyday standard’ food items such as
cheese to promote healthy gastro-
intestinal microflora and to prevent
gastrointestinal illness such as diarrhoea.
DISCUSSION
Some common food items such as
yoghurt, sauerkraut, garlic and cheese
contain probiotics in the form of live
lactic acid bacteria, and/or prebiotics in
the form of fructans, a dietary fibre.
Cheese contains both probiotic bacteria
and the prebiotic dietary fibre inulin. The
regular consumption of cheese has been
associated with a reduction in the risk of
Campylobacter enteritis.
The 2003 Australian Health Care Summit1 and
the 2003 South Australian Generational Health
Review2 have identified a clear need for the
Australian health care system to shift the
current focus on treatment of disease toward
illness prevention, health promotion, and early
intervention. The move toward a stronger focus
on prevention aims to reduce the high economic
and social costs associated with the treatment
of disease. The Commonwealth Department of
Health and Ageing allocated $17.3 million of the
2003-2004 health budget to support preventive
activities such as enhancing the quality use of
medicine, building community awareness for
prevention, and improving the communication
between various primary health care providers.3
A healthy diet plays a pivotal role in disease
prevention and health promotion. The concept of
‘functional foods’ (Table 1) has evolved together
with the recognition that some foods, or food
ingredients, may improve the state of health and
wellbeing and/or reduce the risk of disease.4
The functional food category of the pro- and
pre-biotics (Table 1) has generated interest
regarding their potential influence on human
microflora and consequently on the mainte-
nance of a healthy gastrointestinal system.5
Gastrointestinal illness 
General practitioners frequently deal with
patients suffering from diarrhoea. Reasons
for diarrhoea can be due to viral or bacterial
infections, or other causes such as antibiotic
associated or traveller’s diarrhoea, inflamma-
tory bowel diseases (eg. ulcerative colitis,
Crohn disease), necrotising enterocolitis, or
colon cancer. Approximately 1% of patients
seen by a GP in Australia complain about diar-
rhoeal symptoms, as reported in the
Bettering the Evaluation and Care of Health
(BEACH) surveys from 1998 to 2002.6 This
places diarrhoea among the 20 most frequent
patient complaints in general practice, along-
side nasal congestion (1.0%) or headache
(1.4%).6 Presumed infectious gastroenteritis
generally accounts for 0.7% of all patient
problems managed by GPs.6
Campylobacter infection has been the
most common cause of bacterial gastroen-
teritis in Australia since it became notifiable
in 1991 to the National Notifiable Disease
Surveillance System in all states except
New South Wales.7 Rates of campylobacte-
r iosis are as high as 125 per 100 000
persons per year or 16 124 reported cases
in Australia in 2001.8 Rates in children under
5 years of age are especially high, account-
ing for about 20% of all notifications.9,10
Standard foods
To date, few studies have investigated the rela-
tionship between the consumption of standard
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foods items and the risk of gastrointestinal
illness. Two case control studies comparing the
incidence of Campylobacter gastroenteritis in
relation to food intake, found that some dairy
products, in particular cheese, were associated
with a lower risk of infectious diarrhoea.
Cameron et al10 showed the consumption of
hard (block) cheeses such as cheddar, or
processed soft cheese, was strongly associated
with a 45–64% risk reduction in Campylobacter
diarrhoea in young children, while Schorr et al11
found the consumption of curd or cottage
cheese lowered the risk by 50%. Full cream and
acidified milk (lactic acid bacteria inocluated
cow’s milk) and processed meat (eg. salami)
were also associated with a protective affect
against gastroenteritis (Table 2).12
Probiotics
The fermentation of foods by lactic acid bac-
teria has long been used by humans for food
preservation, as it was the simplest way to
avoid food spoilage before the industrial rev-
olution. Therefore, the human
gastrointestinal tract may have adapted to a
daily supply of live lactic acid bacteria.13
Bacteria are an important part of the human
gut which hosts an estimated 1014 resident
micro-organisms, or 10 times more bacteria
than there are cells in the body.5,14
Fermented foods containing probiotic
lactic acid bacteria include yoghurt, butter-
milk, cheese, gherkins, sauerkraut, brined
olives and soy sauce.13,15–17
Although marketing and research attention
has focussed on yoghurts and fermented milk
drinks as food carriers for probiotic micro-
organisms, these products are not the only
sources and may not be the optimal delivery
system of probiotics to the gastrointestinal
tract.18 For example, the lactic acid bacteria in a
9–15 month old cheddar cheese originate from
the environment and are typically lactobacilli in
numbers similar to those found in fresh
cheeses and yoghurt (107 -108 viable cells/g).17,19
Probiotic functions/health benefits
Lactic acid bacteria can normalise intestinal  
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Table 1. Functional foods
Functional foods are described as
foods or food ingredients that may
provide health benefits and prevent
disease, and can be categorised into 5
groups: dietary fibres, vitamins and
minerals, bioactive substances, fatty
acids and pro-, pre- and syn-biotics
Probiotics are live micro-organisms
which, when administered in adequate
amounts, confer a health benefit to the
host.28 The lactic acid bacteria
Lactobacillus, Bifidobacterium, and
Streptococcus are examples. The
sterile gut of the fetus is initially
colonised by bifidobacteria.25 The adult
gut is colonised by a large number of
lactobacilli from fermented dairy and
plant products13,17
Prebiotics are nondigestible
substances that beneficially affect the
host by selectively stimulating the
growth or activity of a limited number
of resident bacterial species in the
colon.26 The fructans oligofructose, also
known as fructo-oligosaccharides, and
inulin can be regarded as dietary fibres
with prebiotic properties27
Table 2. Standard foods associated with a risk reduction of diarrhoea
Food item Odds ratio 95% CI p value < Study design
Dairy Cheese slices 0.33 0.15–0.71 0.00310 Case control
Block cheese 0.38 0.19–0.76 0.00510 Case control
Acidified milk 0.41* 0.28–0.60* 0.00112 Prospective 
case control
Cottage/curd cheese 0.5 0.3–0.9 not given11 Case control
Full cream milk 0.53 0.29–0.97 0.03610 Case control
Cheese spread 0.55 0.32–0.97 0.03510 Case control
Nondairy Processed meat 0.52 0.32–0.83 0.00610 Case control
* The rate ratio and 95% confidence interval based on the incidence of acute diarrhoea
Table 3. Mechanisms of probiotic activity
Mechanism
Production of inhibitory substances
Organic acids (eg. acetate, butyrate), hydrogen
peroxide
Bacteriocins (exotoxins, eg. nisin kill other bacteria but
not eukaryotic cells) 
Stimulation of the immune system
Intestinal humoral response (eg. IgA)
Cellular response (eg. T and B cells and cytokine
production)
Nonspecific immunity (eg. phagocytosis)
Competitive inhibition of bacterial adhesion sites on















microflora composition, strengthen host
immunity, restore metabolic processes, and
inhibit the growth of pathogens such as
Salmonella, Campylobacter, and
Clostridium.20,21 Table 3 lists some biochemi-
cal and/or celluar effects of probiotics and the
potential benefits of probiotic therapy. 
Prebiotics
Prebiotics represent a second strategy to
improve the balance of intestinal bacteria.
Prebiotic fructans are found in vegetables
such as garlic, artichokes, onions, and leeks,
and in comparable amounts, in cheese and
other dairy products.22,23 Gibson et al24
showed that small alterations in the intake of
the fructans oligofructose or inulin could lead
to significant changes in the balance of the
intestinal microflora. In their study, the
numbers of lactic acid bacteria increased in
both absolute terms and as proportion of
anaerobes.
The role of cheese
Cheese has been strongly associated with
the prevention of bacterial gastroenteritis.10,11
It contains the probiotic lactic acid bacteria
and the prebiotic inulin as stimulant for probi-
otic growth. While some foods contain more
fresh weight inulin than cheese, eg. onion,
garlic and leek, it may be easier to obtain a
higher amount of inulin from cheese.
Furthermore, fructans degrade during
cooking,22 and uncooked cheese is more
likely to be consumed than raw garlic or
onion. Cheese also contains a high percent-
age of other health promoting ingredients
including fatty acids, vitamins A, B and D,
calcium, magnesium and zinc.
Conclusion
Current food marketing strategies often
promote the development of new ‘functional’
food products rather than highlighting the
health benefits of some everyday standard
food items. However, there is a growing
body of evidence that judicious consumption
of some traditional foods can have strong
positive effects on gastrointestinal health.
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